Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Did Hedge Funds See, Inc. (BIDU) Being Pummeled By Gloomy Q3 Outlook?

Page 1 of 2, Inc. (ADR) (NASDAQ:BIDU) has plunged by 13.46% in early morning trading, as the stock felt the market’s cold reception to its gloomy outlook for the third quarter of the year. According to the Chinese electronic commerce firm, it expects revenues in the next quarter to be 18.17 billion yuan to 18.58 billion yuan (about $2.93 billion to $2.99 billion), which is below Wall Street’s expectations of 18.79 billion yuan (about $3.03 billion). The light forecast for Baidu comes as it reported a beat on earnings for the second quarter, with adjusted earnings coming in at $1.81 per share, up 3.3% year-over-year and soundly beating analysts’ estimates of $1.70 per share. Revenues jumped 38% compared to the same quarter last year, to 3.66 billion yuan (about $589.37 million). However,, Inc. (ADR) (NASDAQ:BIDU)’s bottom line was reduced due to higher expenditures, which is also why the firm issued a disappointing forecast for the third quarter. Baidu is focused on ramping up its online-to-offline (O2O) sales and its video streaming business. In the second quarter, selling, general, and administrative expenses jumped by 81% compared to the same quarter last year to 2.71 billion yuan (about $436.39 million) on the back of bigger promotional spending on O2O.

Baidu Inc (ADR) (NASDAQ:BIDU), Icon, app, Symbol, Sign, logo, smarphone

Twin Design /


The disappointing forecast for the third quarter which has punished, Inc. (ADR) (NASDAQ:BIDU) shares early today coincides with an outflow of investments in the first quarter among the hedge funds we track. The total value of holdings of funds still long on Baidu on March 31 decreased by 16.78% quarter-over-quarter, to $7.01 billion. Though slightly offset by the 8.58% drop in the stock’s value from January 2 to March 31, there was also a significant decrease in the number of funds long in the stock by the end of the first quarter, pointing to a clear bearish sentiment among the hedge funds we track. Heading into the second quarter, a total of 75 of the hedge funds tracked by Insider Monkey were long in this stock, down from 95 in the previous quarter, which ranked it as one of the top stocks hedge funds were selling out of in the first quarter.

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 123% and beating the market by more than 66 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise rather than large-cap stocks.

We also track insider selling activity of companies in an effort to judge the sentiment of company executives, but there have been no cases of insider trading of Baidu reported with the SEC this year.

With all of this in mind, let’s analyze new hedge fund activity regarding, Inc.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!